Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Curiosis, Inc.

Market Cap 195B 127M 111M 103M 96.1M 180M 11.99B 181M 1.22B 472M 5.9B 477M 467M 20.5B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 176M 115K 100K 92.95K 87.01K 163K 10.86M 164K 1.1M 427K 5.35M 432K 423K 18.56M EV / Sales 2026 *
11.4x
EV / Sales 2027 * 7.37x
Free-Float
71.28%
Yield 2026 *
-
Yield 2027 * -
1 day-7.43%
1 week-6.41%
Current month-21.51%
1 month-37.76%
3 months-61.11%
6 months-59.38%
Current year-47.86%
1 week 24,500
Extreme 24500
34,450
1 month 22,150
Extreme 22150
44,500
Current year 22,150
Extreme 22150
88,000
1 year 22,150
Extreme 22150
96,400
3 years 22,150
Extreme 22150
96,400
5 years 22,150
Extreme 22150
96,400
10 years 22,150
Extreme 22150
96,400
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2015
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/01/2015
Director/Board Member 57 01/12/2016
Director/Board Member 56 01/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-6.41% - - 127M
+0.63%-1.01%+16.77%-11.66% 173B
+1.14%-1.04%-20.14%+25.65% 144B
-0.33%-1.63%-9.79%-25.47% 125B
+0.76%-3.45%-55.29%-16.07% 67.32B
+0.78%+2.64%+18.33%-4.09% 50.3B
-0.58%-1.16%-25.96%-32.70% 43.8B
+2.20%-2.14%+9.95%+7.38% 35.89B
-0.44%-0.03%+3.74%+34.39% 34.9B
+0.72%-5.51%-13.59%-22.65% 28.02B
Average -0.26%-1.85%-8.44%-5.02% 70.25B
Weighted average by Cap. +0.54%-1.89%-7.21%-4.84%

Financials

2026 *2027 *
Net sales 15.4B 10.06M 8.77M 8.12M 7.6M 14.26M 949M 14.35M 96.37M 37.35M 467M 37.76M 36.95M 1.62B 23.9B 15.61M 13.61M 12.61M 11.8M 22.13M 1.47B 22.27M 150M 57.96M 725M 58.6M 57.35M 2.52B
Net income - -
Net Debt -18.4B -12.02M -10.48M -9.71M -9.09M -17.04M -1.13B -17.14M -115M -44.63M -558M -45.12M -44.15M -1.94B -18.4B -12.02M -10.48M -9.71M -9.09M -17.04M -1.13B -17.14M -115M -44.63M -558M -45.12M -44.15M -1.94B
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
97
Date Price Change Volume
19/06/26 25,550.00 -7.43% 55,554
18/06/26 27,600.00 -17.12% 124,956
17/06/26 33,300.00 +11.19% 194,991
16/06/26 29,950.00 +15.19% 161,081
15/06/26 26,000.00 -4.76% 29,886
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!